Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of production method of lovastatin with high yield

A technology of lovastatin and a production method, which is applied to the production method and the field of Monascus bacteria used in the production method, can solve the problems of staying and not forming an industrial scale, and achieve the effects of high production capacity and improved quality

Active Publication Date: 2018-05-01
山东中惠生物科技股份有限公司 +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the limitation of output and production cost, the research on the production of lovastatin by liquid fermentation has remained at the laboratory level and has not formed an industrial scale

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of production method of lovastatin with high yield
  • A kind of production method of lovastatin with high yield
  • A kind of production method of lovastatin with high yield

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Mutation and preliminary screening of Monascus strain with high lovastatin production

[0043] Wash the spores from the growth slant of the initial strain Monascus purpureus with normal saline to obtain a spore suspension, inoculate the seed medium, and cultivate for about 36 hours. Take the bacterial suspension, filter it with sterile gauze, and shake it with glass beads Disperse to a single spore suspension and collect the single spore suspension for later use.

[0044] Add an equal volume of monospore suspension and 1% lithium chloride solution into a sterile test tube, mix well, let stand for 3 hours, and finally dilute 100 times with sterile phosphate buffer to terminate the reaction.

[0045] Draw 1 mL of the spore dilution treated with lithium chloride and inject it into a sterile small dish, and place it under laser irradiation. The irradiation time is 10 min. Laser wavelength: 632.8 nm, the irradiation power density is 17.6 mw / cm2.

[0046] After the mutagen...

Embodiment 2

[0048] Production of Lovastatin by Liquid Fermentation of Monascus

[0049] Fermentation strain: Monascus purpureus

[0050] Seed Medium:

[0051] Rice flour 3 g, glucose 2 g, NaNO 3 0.2 g, peptone 1.5 g, MgSO 4 ·7H 2 O 0.05 g, KH 2 PO 4 0.15 g, add water to 100 mL.

[0052] Fermentation medium:

[0053] Rice flour 7 g, glycerin 5 mL, NaNO 3 0.2 g, peptone 1.5 g, MgSO 4 ·7H 2 O 0.05 g, KH 2 PO 4 0.15 g, add water to 100 mL.

[0054] Training conditions:

[0055] The Monascus spores were scraped from the plate and transferred to a Erlenmeyer flask containing 50 mL of seed medium, and cultured at 30°C for 3 days. According to the inoculation amount of 15%, the grown seed culture medium was transferred to 150 mL fermentation medium, and cultured on a shaker at 150 r / m at 30°C for 3 days, then cultured on a shaker at 150 r / m at 24°C for 20 days.

[0056] Sample processing and testing:

[0057] After the fermentation broth was centrifuged at 10,000 g for 10 min, 2...

Embodiment 3

[0060] Production of lovastatin by liquid state fermentation of monascus after mutagenesis of the present invention

[0061] Fermentation strain: Monascus purple

[0062] Seed Medium:

[0063] Rice flour 3 g, glucose 2 g, NaNO 3 0.2 g, peptone 1.5 g, MgSO 4 ·7H 2 O 0.05 g, KH 2 PO 4 0.15 g, add water to 100 mL.

[0064] Fermentation medium:

[0065] Rice flour 7 g, glycerin 5 mL, NaNO 3 0.2 g, peptone 1.5 g, MgSO 4 ·7H 2 O 0.05 g, KH 2 PO 4 0.15 g, add water to 100 mL.

[0066] Training conditions:

[0067] The spores of Monascus MPB3 were scraped from the plate and transferred to a Erlenmeyer flask containing 50 mL of seed medium, and cultured at 30°C for 3 days. According to the inoculation amount of 15%, the grown seed culture medium was transferred to 150 mL fermentation medium, and cultured on a shaker at 150 r / m at 30°C for 3 days, and then cultured on a shaker at 150 r / m at 24°C for 20 days.

[0068] Sample processing and testing:

[0069] After the fe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of microbes, and in particular relates to a production method of high-yield lovastatin and Monascus used in the production method, which includes the mutagenesis of strains and the use of the mutagenesis strains for fermentation. The invention is beneficial The effect is: the mutagenic strain of the present invention and the method for producing lovastatin thereof, compared with conventional Monascus production strains and production methods, its lovastatin output can reach more than 1650 mg / L, and the lovastatin production capacity is higher, Improved lovastatin quality.

Description

technical field [0001] The invention belongs to the technical field of microorganisms, and in particular relates to a production method of high-yield lovastatin and Monascus bacteria used in the production method. Background technique [0002] Lovastatin is a physiologically active substance that can inhibit the synthesis of cholesterol in the body. Since 1987, the American Merck Company developed the lovastatin series and launched a new generation of cholesterol-lowering drugs. Patients welcome. [0003] Currently, lovastatin production strains are mainly Aspergillus terreus and Monascus. The fermentation yield of Aspergillus terreus is high, but for safety considerations, the fermented product of Aspergillus terreus needs to be extracted with an organic solvent, or undergo chemical synthesis and other steps to obtain pure closed-loop lovastatin. These are the main components of pharmaceutical lipid-lowering drugs currently on the market. Closed-loop lovastatin itself is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12P17/06C12R1/66
Inventor 赵吉兴李纪顺吴远征李耀杨合同陈泉扈进冬王贻莲闫芃韩岩君
Owner 山东中惠生物科技股份有限公司